关于“卡介苗治疗非肌层浸润性膀胱癌患者的预后因素：四项随机CUETO试验数据的多变量分析”的编辑评论 - Suppr

Suppr

超能文献

Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

作者信息

Sylvester Richard J

机构信息

EORTC Data Center, Brussels, Belgium.

出版信息

Eur Urol. 2008 May;53(5):1002. doi: 10.1016/j.eururo.2007.10.007. Epub 2007 Oct 15.

DOI:10.1016/j.eururo.2007.10.007

PMID:17950990

Abstract

摘要

相似文献

Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Eur Urol. 2008 May;53(5):1002. doi: 10.1016/j.eururo.2007.10.007. Epub 2007 Oct 15.

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Eur Urol. 2008 May;53(5):992-1001. doi: 10.1016/j.eururo.2007.10.006. Epub 2007 Oct 15.

Editorial comment to Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.

Int J Urol. 2010 Sep;17(9):766-7. doi: 10.1111/j.1442-2042.2010.02595.x.

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.

Eur Urol. 2010 Feb;57(2):e7-9; author reply e10-1. doi: 10.1016/j.eururo.2009.10.033. Epub 2009 Nov 10.

Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.

Int J Urol. 2010 Sep;17(9):759-66. doi: 10.1111/j.1442-2042.2010.02584.x. Epub 2010 Jul 4.

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.

J Urol. 2007 May;177(5):1727-31. doi: 10.1016/j.juro.2007.01.031.

What is the optimal BCG dose in non-muscle-invasive bladder cancer?

Eur Urol. 2007 Nov;52(5):1300-2. doi: 10.1016/j.eururo.2007.05.010. Epub 2007 May 22.

Eur Urol. 2010 Aug;58(2):e23; author reply e24-5. doi: 10.1016/j.eururo.2010.05.032. Epub 2010 Jun 2.

Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.

J Urol. 2008 Jul;180(1):110-5. doi: 10.1016/j.juro.2008.03.038. Epub 2008 May 15.

Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.

Urology. 2006 Jun;67(6):1216-23. doi: 10.1016/j.urology.2005.12.014.

引用本文的文献

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

Front Pharmacol. 2018 Jan 12;8:977. doi: 10.3389/fphar.2017.00977. eCollection 2017.

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

J Transl Med. 2010 Jun 8;8:54. doi: 10.1186/1479-5876-8-54.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

作者信息

Sylvester Richard J

机构信息

EORTC Data Center, Brussels, Belgium.

出版信息

Eur Urol. 2008 May;53(5):1002. doi: 10.1016/j.eururo.2007.10.007. Epub 2007 Oct 15.

DOI:10.1016/j.eururo.2007.10.007

PMID:17950990

Abstract

摘要